Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | CASP1 | P29466 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | CASP7 | P55210 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | PTPRC | P08575 | 2/20 | 0.52 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11550711 | 0.98 | GPR3 (0.61) | GPR3L3MBTL1NPSR1KDM4EGAA | |
| SCHEMBL14174131 | 0.96 | GPR3 (0.59) | GPR3L3MBTL1NPSR1KDM4EGAA | |
| SCHEMBL16900704 | 0.91 | MEN1 (0.62) | GPR3L3MBTL1NPSR1PTPRCCHEK1 | |
| SCHEMBL4934590 | 0.89 | CA12 (0.53) | GPR3L3MBTL1NPSR1KDM4EGAA | |
| SCHEMBL29641986 | 0.89 | CA12 (0.53) | GPR3L3MBTL1NPSR1KDM4EGAA | |
| SCHEMBL30827024 | 0.89 | CA12 (0.53) | GPR3L3MBTL1NPSR1KDM4EGAA | |
| SCHEMBL5121583 | 0.88 | GPR3 (0.64) | GPR3L3MBTL1NPSR1KDM4EGAA | |
| SCHEMBL5185936 | 0.86 | CA12 (0.47) | GPR3L3MBTL1NPSR1KDM4EGAA | |
| SCHEMBL14174169 | 0.82 | MAOA (0.47) | GPR3L3MBTL1NPSR1KDM4EGAA | |
| SCHEMBL29387122 | 0.80 | GPR3 (1.00) | GPR3L3MBTL1KDM4ECHEK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0342433-A2 | Substituted dibenzothiaphenes | AMERICAN CYANAMID COMPANY (US) | 1989-11-23 | — | — | EP | claimed |
| EP-4263544-B1 | INDOLO[3.2.1-JK]CARBAZOLE-6-CARBONITRILE DERIVATIVES AS BLUE EMITTERS IN OLEDS | UDC IRELAND LTD (IE) | 2026-05-13 | — | — | EP | disclosed |
| EP-4676208-A2 | NITROGEN-CONTAINING HETERO-AROMATICS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2026-01-07 | — | — | EP | disclosed |
| US-20240101560-A1 | NITROGENOUS HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | UDC IRELAND LIMITED (IE) | 2024-03-28 | — | — | US | disclosed |
| WO-2022129113-A1 | NITROGENOUS HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2022-06-23 | — | — | WO | disclosed |
| WO-2022129114-A1 | NITROGENOUS COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2022-06-23 | — | — | WO | disclosed |
| WO-2022129116-A1 | INDOLO[3.2.1-JK]CARBAZOLE-6-CARBONITRILE DERIVATIVES AS BLUE FLUORESCENT EMITTERS FOR USE IN OLEDS | MERCK PATENT GMBH (DE) | 2022-06-23 | — | — | WO | disclosed |
| EP-3663300-B1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2021-09-29 | — | — | EP | disclosed |
| US-8273769-B2 | Phenoxy acetic acid derivatives | MERCK SERONO SA (CH) | 2012-09-25 | — | — | US | disclosed |
| EP-2396295-A1 | PHENOXY ACETIC ACID DERIVATIVES | Merck Serono S.A. (CH) | 2011-12-21 | — | — | EP | disclosed |
| US-20110288066-A1 | PHENOXY ACETIC ACID DERIVATIVES | MERCK SERONO S.A. (CH) | 2011-11-24 | — | — | US | disclosed |
| US-7910653-B2 | Ionene polymers; for use in electrochemical cells; fuel cells; polymerization catalysts | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-03-22 | — | — | US | disclosed |
| US-7868086-B2 | Arylene fluorinated sulfonimide polymers and membranes | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-01-11 | — | — | US | disclosed |
| US-7838612-B2 | Arylene fluorinated sulfonimide compositions | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-11-23 | — | — | US | disclosed |
| WO-2010092043-A1 | PHENOXY ACETIC ACID DERIVATIVES | MERCK SERONO S.A. (CH) | 2010-08-19 | — | — | WO | disclosed |
| US-20090136817-A1 | ARYLENE FLUORINATED SULFONIMIDE POLYMERS AND MEMBRANES | U.S. DEPARTMENT OF ENERGY | 2009-05-28 | — | — | US | disclosed |
| US-20080214732-A1 | PROCESS FOR THE PREPARATION OF ARYLENE FLUORINATED SULFONIMIDE POLYMERS AND MEMBRANES | U.S. DEPARTMENT OF ENERGY | 2008-09-04 | — | — | US | disclosed |
| US-20080177088-A1 | ARYLENE FLUORINATED SULFONIMIDE COMPOSITIONS | U.S. DEPARTMENT OF ENERGY | 2008-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080177088-A1 | ARYLENE FLUORINATED SULFONIMIDE COMPOSITIONS | FES, FLNA, FLNB | GPR3 3308/4885L3MBTL1 4840/4885NPSR1 2385/4885 |
| US-20110288066-A1 | PHENOXY ACETIC ACID DERIVATIVES | HRH2, HRH1, HRH3 | GPR3 434/4885L3MBTL1 4821/4885NPSR1 3017/4885 |
| US-20240101560-A1 | NITROGENOUS HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | NES, NCL, NPM1 | GPR3 3926/4885L3MBTL1 2227/4885NPSR1 1275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.